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Adducted Proteins for Identification of
Endogenous Electrophiles
by MargaretaTornqvist12 and Antti Kautiainen
Chemically reactivecompounds intissuescanbemonitoredthroughtheirproductsofreactionwithbiomacromolecules.
Forthe purposeofin vivodosemonitoring, hemoglobin (Hb) hasbeen preferred to DNAbecause ofitswell-defined life
spanandmorefacilechemicalidentificationofadducts.ThroughtheN-alkylEdmanmethod, adductstotheN-terminals
(valines) oftheglobinchainsaremeasured mam spectrometrically withhighsensitivity. Instudiesoflowmolecularweight
adducts from occupational exposures ortobacco smoke, background levels werefound in nonexposed control persons.
Insomecasestheorigin oftheseadductscouldbedetermined. Forinstance, the2-hydroxyethyl adduct hasbeen shown
tooriginate fromethyleneoxide, ametaboliteofendogenously producedethene. Themeasuredlevel, about20pmole/g
globin, agreeswellwiththeethyleneoxidedosecalculatedfromexpiredethene. Animal studiesindicatecontributionsfrom
theintestinal floraand dietaryfactors. Anaveragebackground levelofabout200pmole/gglobinofmethylvaline hasbeen
observedinunexposedhumans. From reaction-kinetic studiesofS-adenosylmethionine (SAM), it has been shown that
thebackground mainlyoriginates fromSAM. Intwinstudies, agenetic influence onthelevel hasbeenshown. Further-
more, a contribution from tobacco smoking to the level was demonstrated in these studies. Certain aldehydes, e.g.,
malonaldehyde, havebeen showntoberelated todietary factorsandlipid peroxidation. Thesestudiesshowtheusefulness
ofthemethod ina search forreactivecompounds inthebody, withtheultinategoalofassessingthetotalgenotoxic load.
Introduction
In vivo dose monitoring by means of adducts to macro-
molecules and characterization ofelectrophilic reagents of en-
dogenous origin in humans not knowingly exposed to car-
cinogens is of interest for several reasons. Primarily, these
studies are an important step in assessing the total load of
mutagensandcarcinogens inhumanpopulations andindevelop-
ingpreventive measureswhentheassociated risks arehigh. Fur-
thermore, studies ofthesekinds arerequired fortheoptimization
of dose monitoring of low molecular weight exogenous car-
cinogensbecausebackgroundofadducts identical withthe ones
to be measured have been encountered in many cases (1-3).
With these purposes inmind, the present paper summarizes
the present status ofwork onlow molecularweightelectrophiles
inhumans notknowinglyexposed tocarcinogens. With few ex-
ceptions, measurementofspecific DNAadducts with sufficient
sensitivity isnotyetpossible, andthisis one reasonwhythework
has focused onmeasuringadductstohemoglobin(Hb). Itshould
be remembered that demonstrated Hb adducts are a good sur-
rogate forthecorresponding DNA adducts (4), therelative rate
offormationofwhich is easily established inanimalexperiments
with labeled compounds.
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TheN-alkyl Edman method (1,5) permits the measurement,
withhighresolvingpower, ofspecificadducts totheaminoter-
minals, valines, of the globin chains. Of importance to the
clarificationoftheoriginofadducts totheN-terminals isthatN-
alkylvalines, as compared to S-alkylcysteines and N- or NT
alkylhistidines, arenotmisincorporated inproteinsynthesis(6).
Valine-N adducts therefore reflect in vivo formation through
chemical reaction, provided that artifactual formation of the
sameadductsduringstorageandpreparationofsamplesiscon-
trolled(7). Artifactformation, whichhasbeendemonstratedfor
adducts from simple epoxides and malonaldehyde, concerns
otheraminoacids as well. Duetothemildderivatization condi-
tions, the monitoring ofvalineadducts is advantageousbecause
theformationofadducts [e.g., duringacidoralkaline hydrolysis
(8)] is avoided.
TheN-alkyl Edmanmethod involves isolationandderivatiza-
tion of globin with pentafluorophenyl isothiocyanate, the
resultingN-alkylamino acidpentafluorophenylthiohydantoin be-
ing measured by GC-MS. Details of procedures are given
elsewhere (1,5,9). For N-alkylidenevalines (i.e., Schiff bases
from aldehydes), derivatization is preceded by reduction to
secondary amines (10).
N-Alkylvalines
N-(2-Hydroxyethyl)valine
Measurement. N-(2-Hydroxyethyl)valine (HOEtVal)hasbeen
extensively studied with the N-alkyl Edman method, ethylene
oxidebeingused as amodelcarcinogenduring methoddevelop-TORNQVISTETAL.
ment. Elevated levelsofHOEtVal areobserved as aresultofoc-
cupational exposure toethyleneoxide orethene, which is con-
verted to ethylene oxide, and in smokers due to the content of
ethene inthesmoke (11). In all studies ofexogenously exposed
populations, abackground levelofHOEtValhasbeenmeasured
in theunexposed control individuals. Similarbackground levels
havebeenobservedinlaboratoryanimals. Inearlystudieswith
Hbhydrolysates fromoccupationally unexposed persons, rather
highbackground levelsofhydroxyethylhistidines wereobserved
(12,13). In studies ofvaline adducts withthe more sensitiveN-
alkyl Edman method, it was shown that there was a large con-
tribution (85 pmole/g globin per 10 cigarettes/day) to the
background level ofHOEtVal due to smoking (9,14). Still, the
HOEtVal level in nonsmokers was ratherhigh (25-110pmole/g
globin) (14), but withthedevelopmentofthemethodthe levels
have decreased considerably. It appears that the lower, recent
valuesaround20pmole/g(9) arecorrect. Thedecreasefromthe
earlier determinations is to some extent due to an improved
resolving powerintheanalysisandmainly theavoidanceofar-
tifact formation ofHOEtVal during storage.
Unexpectedly highbackgroundlevelsofHOEtVal foundin a
studyofunexposednonsmokerswereshowntobeduetoadducts
being formed as artifactsduring storage ofHb samples (7). In
vitrostudieshaveshownthattheformationofHOEtValasanar-
tifactisdependent onoxidativeprocesses, maybewithetheneas
an intermediate(7). Theprocess wasshown tobeenhancedby
lyophilization ofsamples. Artifactual HOEtVal has been found
at levels covering the whole range (up to 30 nmole/gglobin) of
whatcouldbeexpected fromoccupationalexposuretoethylene
oxide. Therefore, precautionsagainstartifactformation have to
be taken in all studies of HOEtVal, particularly in studies of
background levels. Storageasprecipitatedglobinshassofarbeen
shown tobesafeinthisrespect(7). Theartifactproblemisofim-
portance tothe extentthatbloodbankmaterialswillbeusedfor
mapping background levels of adducts; this also concerns
alkylidenevalines.
An intercalibration study between fourlaboratories measur-
ing HOEtVal adducts illustrates the difficulties ofattaining the
resolving power needed fordetermining lowbackgroundlevels
(15). The resolving power can be increased by technically im-
proving the MS analysis, furtherpurifying thederivatized sam-
ples (16), and/or enriching adduct-carrying chains (17).
In 10 studies involvingatotal ofabout 110 persons, wherear-
tifactformationand contamination werecarefully controlledand
occupationallyexposedindividualsandsmokerswereexcluded,
a mean background level of 18 pmole/g globin, range 8-30
pmole/g, wasobtained. There are strong reasons toassumethat
these values arecorrect. Afewanalysesonmiceandratsfedstan-
dard laboratory diets give about the same values. Background
levels in the same individual may vary, as shown by meas-
urements over a 15-monthperiod (Table 1). It is possible (p
0.04) that sample no. 4 was precededby an exposure or that it
reflects an increasedendogenousproductionofethene/ethylene
oxide.
The contributions touncertainty were measuredin acoupleof
studies showing thecoefficientsofvariation (CV) forderivatiza-
tion, injection, andreading tobe4.7,7.8, and 4.5%, respectively,
corresponding to a total CVof 10.2%. Greatervariationmay oc-
cur onoccasions with unfavorableanalyticalconditions, which,
Table 1.Variationduring 15monthsinthebackgroundlevelofHOEtValin
blood samplescollectedon different occasions from one person.
Sample number
1 2 3 4 5 6
HOEtVal, pmole/ga 18.6 22.7 21.4 28.2 24.6 18.9
HOEtVal, N-(2-hydroxyethyl)valine.
aMean, 22.7pmole/g; coefficient ofvariation, 14.7%.
however, canbedetected. Asystematicerror(duetouncertain-
ty inthetruelevelinthestandardproteins) may amountto 15%.
Origin. Ithasbeen shownearlierthatethene isendogenous-
ly formedinlivingorganisms includingman (18). Experiments
were conducted to determine the extent that endogenously
formed ethene could give rise to the observed background of
HOEtVal inhumans (19). Theethenecontentintheexhaledair
and the HOEtVal contentin Hb weredetermined in unexposed
nonsmokers, and in the same individuals the inhalation phar-
macokineticsofethene were studied inan independent experi-
ment. Pharmacokinetic parameters for ethylene oxide were
known from previous studies. By the application of a phar-
macokinetic model to these data, the steady-state level ofeth-
ylene oxide was calculated to be 0.17 nmole/L tissue. The ex-
posuretoenvironmentalethene, estimatedto 15 ppb, wouldgive
a further contribution of0.08 nmole/Ltissue, the total dose of
ethylene oxide, [EO],to, being 0.25 nmole/L tissue.
Thevaline-adductlevel, [R-Val], isdeterminedbytheratecon-
stant, kal, mean concentration, C, and time, t, according to
[R-Val] = kva- C * t (1)
where C * t = dose (D).
Inchronicorintermittentexposure,asteady-stateadductlevel,
[R-Val],,, is reached inoneerythrocyte life span, te, = 18 weeks,
the steady-state adduct level corresponding to the cumulative
levelduringthetimete,I2. Fromkv,, forethyleneoxide [5 x 10-5
L/g
- hr (20)], the expected level of HOEtVal may thus be
calculatedaccording to
[HOEtVal]ss(mole/g) = ka,l ' [EO]tOt ter - 5 * 10 5(L/g-hr) 2
0.25 v 10 (mole/L)1 2 (hr)
-1
19. 102 mole/g
= 19pmole/g
ThisisinagreementwiththevalueofHOEtValinthestudiedper-
sons, 20 ± 4 (SD) pmole/g globin.
Afewexploratoryexperimentswithmicewerecarriedoutto
shedlightondeterminantsofthebackground levelofHOEtVal
(21). A lowervalueofHOEtVal (by about 10pmole/g) was ob-
tained in germ-free mice as compared to control animals. In
another experiment, a higher level (by about 15 pmole/g) was
observed inmice fed anunsaturated-fatdiet(sunflowerseedoil)
comparedtomicefedasaturated-fatdiet(coconutoil). In more
recentstudiesofdifferentfatdietsandinductionoflipidperox-
idation, onlyaslightlysignificantincrease(about 1 pmole/g) was
found in mice fed the unsaturated-fat diet (soya oil) (22).
However, micefedanormallaboratorydiethaveshownahigher
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background (afewpicomoles) thanmicefedasoya-oildiet(un-
published data), which indicates that the soya-oil diet is un-
favorable in studies withthispurpose. Thesefindings, together
with thehumanstudies, arecompatiblewithendogenously pro-
duced ethenebeing the major sourceofbackground HOEtVal.
Ethenehasbeen showntobeproducedbyentericbacteriaandin
peroxidation oflipids and methionine (7,18,21).
N-(2-Hydroxypropyl)valine
Hydroxypropyl adducts to histidine and valine have been
measuredinpropyleneoxide-exposedpersons (23). Anincreas-
edlevelofN-(2-hydroxypropyl)valine (HOPrVal)hasbeendeter-
mined in animals with exposure to propene in motor exhausts
(5). In smokers, an increment ofHOPrVal ofabout 2 pmole/g
globin per 10 cigarettes/day has been observed (24). Non-
smokers show a background of about 2 pmole/g of HOPrVal
(24). However, thereisstillanuncertaintybyatleastafactorof
2 intheabsolutequantification ofHOPrVal. Thedifficulties of
measuring lowlevelsofHOPrValdependaboveallontheresolv-
ingpowerattainedwiththestandardanalytical procedurebeing
insufficient. HOPrValhassofarnotbeenshowntobeformedas
anartifactduring storage, buthasbeenshowntobeformeddur-
ing globin precipitation from an acetone-HCl solution in the
rangeof 10pmole/g, probably fromthe acetone reacting inthe
enol form. Itisunlikely thatpropeneinenvironmental tobacco
smoke(25)andurbanairpollution(26)accountfortheobserved
background levels ofHOPrVal. Pathways for endogenous pro-
duction ofpropene or some other precursor are at present not
known.
N-Methylvaline
A relatively highbackground levelofN-methylvaline (MeVal)
inHb, about500pmole/g, wasobservedinanearlierstudy(27).
Due to interindividual variationofthisbackground, theexpected
increment frommethylators intobaccosmokewasnotdetectable
with statistical significance in smokers. This situation was im-
proved in a later study (28) in which twin pairs discordant for
smoking wereinvestigated. Thestudyshowedanincrementfrom
smoking of about 3.5 pmole/g per cigarette/day to be highly
significant (p < 0.001) whenitwascalculatedasthewithin-pair
differencebetween smokingandnonsmoking twins. Inaddition,
thehypothesis thatthevariations inthebackground were part-
ly hereditary was confirmed (p < 0.001; Fig. 1). It is notewor-
thythatacorrelationbetweenthebackgroundlevelsofMeValand
HOEtVal (28) (p < 0.05)andperhapsalsoHOPrValisindicated.
This might be interpreted by the existence ofa common link,
such as detoxification, in the metabolism of the different
alkylators.
In this later study (28), the background level ofMeVal was
foundtobelower(mean220, range 150-300pmole/g). Thiswas
partly due to improved calibration, a step which has been
somewhatcumbersome in theanalysis ofMeVal (9,27). MeVal
has notbeen shown to beformed as an artifactduring storage.
Theobservedhigh levelsofS-methylcysteine (29) and ring-N-
methylhistidines (27) mightbedue tomisincorporation (6).
In the previous study (9,27), S-adenosylmethionine (SAM)
was indicated to be a possible source ofbackground methyla-
tions. A determination ofthe second-order rate constant, kl,.
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FIGURE 1. Correlationofthebackground levelsofN-methylvaline(MeVal) in
monozygotic twinsdiscordant forsmoking. Levels in smokingtwinsadjusted
forthecontributionfromsmoking [estimatedtobe 3.5pmole/gpercigarette
per day; Tomquist et al. (28)].
for methylation of the N-terminal of Hb confirmed this hy-
pothesis (manuscriptinpreparation). Fromthevalueofthecon-
stant,kvw = 3 x 10-8(L/g *hr) andtheconcentrationofSAM in
erythrocytes, 3.5 1tM (30), the expected level of MeVal is
calculated according to Equation 1 tobe 160 pmole/g.
This expectation is compatible with the observed levels.
Anothercellularmethylator, choline, was foundtoreactatleast
104times more slowly than SAM. Even ifthe concentration in
erythrocytesofcholineishigherthanthatofSAMby onetotwo
ordersofmagnitude, this sourceisexpected togiveasmall con-
tributiononly. This is alsothe casewith methyl chloride, part-
ly formed from SAM (27).
N-Alkylidenevalines
Reactivity ofAldehydes
Saturatedaldehydes reactreversibly withaminogroups(e.g.,
N-terminal valine in Hb) through Schiff-base formation. a, ,3-
unsaturated aldehydes can also react through 1,4-addition.
Schiff-bases canbetransformed to stable secondary aminesby
reduction with NaBH4, forexample. o-Hydroxycarbonyl com-
pounds, such asglycolaldehyde, giverise to stable2-oxoalkyl-
amines through Amadori rearrangement of initially formed
Schiff-bases (31), and in the reduction ofthese amines 2-hy-
droxyalkylamines areformed. Schiff-bases mayalsorearrange
to stablecyclicimidazolidinone derivativesthatarenotreducible
(32).
Measurement ofAdducts
Hemoglobinadducts fromaldehydescanbemonitoredbythe
N-alkylEdmanmethodafterreductionwithNaBH4tosecondary
amines (see Table 2). Considering that aldehyde adducts are
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Tible2. Adducts to N-terminal valine in human hemoglobin fromsomeendogenously formed aldehydes.
Reduced adduct to
N-terminal valine Formula Mean (range), nmole/g Unreduced adduct Origin
Methyl CH3- - 4 CH2s Formaldehyde
(2-12)
Ethyl CH3CH2- - 2 CH3CH= Acetaldehyde
(1-5)
2-Hydroxyethyl HOCH2CH2- - 3 HOCH2CH= Glycolaldehyde
(2.5-5)
2-Hydroxypropyl CH3CHCH2- - 7 CH3CCH- Methylglyoxal
OH (4-10) OH O
3-Hydroxypropyl HOCH2(CH2)2- - 0.3 CHCH=CH- Malonaldehyde
(0.2-0.9) o
Hexyla CH3(CH2)5- - 0.01 CH3(CH2)4CH= Hexanal
(0.0-0.02)
aDetermined as described by Kautiainen (35).
unstable and that artifact formation could presentproblems in
analysis, work-upprocedures forblood samples tobeanalyzed
for aldehyde adducts were carefully studied. It was found that
samples had tobe reduced ashemolysatetoavoidcontamination
from aldehydes present insolvents and toavoid possible loss of
reversibly boundaldehydeadducts (10). Thereproducibility of
theanalysis hasbeenstudiedwithregard totheaddedamountof
NaBH4, timeofstorage, etc. Furthermore, thevariations ofone
person's adduct levels were studied. It was concluded that the
measurementofmethyl andethyl adducts waslessreproducible
than theadducts fromotheraldehydes. Sofar, the reason forthe
large fluctuations inthe levelsofmethylandethyl adducts is not
known. Theformation ofprecursors ofthese adducts (i.e., for-
maldehyde andacetaldehyde) during thereduction ofhemolysate
cannot be excluded.
Malonaldehyde (MA) has been shown tobe formed in stored
blood (33) and inbloodplasma(34). High levelsofMAadducts
(up to 40 nmole/g globin) were measured in samples from red
bloodcells storedfrozenforseveral years. Alsohighlevelsofthe
adductfromhexanal, anotheraldehydeformedbylipidperoxida-
tion, were found in thesesamples. These results illustrate that,
becauseperoxidation processes mayproceed infrozenbiological
material, bloodsamples should notbestored asfrozenredblood
cells.
Mean valuesand ranges oflevels ofadductsobtained in unex-
posed personsfrom somealdehydesthatareformedendogenous-
ly as intermediates in biochemical reactions are listed in Table
2. Current studies indicatethatthelevelsofmethylandethyl ad-
ducts can be influenced by different treatments ofanimals. This
indicates that, inspiteoftheanalyticaldifficultiesdescribed, the
adduct levels measured are approximately correct.
Origin
Major sources ofendogenous formaldehyde are metabolism
ofglycineand serine. Othercompounds thathavebeenfound to
yield formaldehyde include choline, dimethylaminoethanol,
dimethylglycine, and methionine (36). Acetaldehyde isthe first
metaboliteofethanol, andraised Hbadduct levelshavebeen seen
in alcoholics (37). Acetaldehyde is produced endogenously by
intestinal bacteria from carbohydrates (38). Glycolaldehyde is
formed as an intermediate in the oxidative degradation ofthe
amino acidstryptophan, tyrosine, andphenylalanine (39). Itis
also formed when ethanolamine is deaminated toglycine (40).
Thepathwaybywhichmethylglyoxalisformedislessknown, but
it canbeformedinmammaliantissues, viatheaminoacetone cy-
cle, fromglycineandthreonine. In sometissuesmethylglyoxal
formed enzymatically from acetoacetate, lactaldehyde, and
aminopropanol (41). Malonaldehydeandhexanal areproduced
by peroxidationofunsaturatedfattyacids, especiallyarachidonic
acid (42). Malonaldehyde is also formed in thebiosynthesis of
prostaglandins (43).
The adducts ofMA have been the most extensively studied.
The background level of MA adduct to valine (MA-Val) in
humanHbisabout0.3 nmole/gglobin, andinmiceand rats fed
standarddietitisabout4and0.6 nmole/gglobin, respectively.
Increased levelsofMA-Val havebeenobservedinmiceafterthe
induction oflipid peroxidation with carbon tetrachloride (10).
The influenceofthedietary fatty-acidcompositionshowedthat
mice fed a soya-oil-based diet (rich in polyunsaturated fatty
acids) had ahigher background level ofMA-Val than mice fed
acoconut-oil-based diet(rich in saturated fattyacids) (22). The
levels ofadducts were 4.5 nmole/g and 2.9 nmole/g globin in
animalsfed asoya-oil-andacoconut-oil-based diet, respectively.
Micefedthesoya-oil-based dietalsoshowed increased suscep-
tibility toinducedlipidperoxidation. In a currentstudy, nodif-
ference in the MA-Val level has so far been seen between
smokers andnonsmokers (Tornqvistetal., unpublished data).
Assuming that the adducts of MA to N-terminal valine are
stableandusingthe second-order rate constant forthe reaction
ofMAwithvaline,kw [3.2 x 10i4L/g-hr(10)], theadduct level
canbeusedforthecalculationofthe averageconcentration (Eq.
1). Thevaluesobtained fortheconcentration offree MA in red
blood cells was 30 nM in mice (ter = 40 days) fed standard
laboratory dietand0.7 nM in humans. The difference between
the levels inmice andhumans mightreflectthe metabolic rates
ofthedifferentspecies, which, as shownby Adelman etal. (44),
correlates withoxidativedamage. A fewotheraldehydes, inad-
dition toMAandhexanal, which areformedperoxidatively from
Table3.AdductsfromendogenousalkylatingagentstoN-terminalvalinein
hemoglobinfrom unexposed persons.
Adduct to
N-terminal valine Mean (range), pmole/g Origin
2-Hydroxyethyl 18 (8-30) Endogenously produced
ethene
2-Hydroxypropyl - 2 (<1--10) ?
Methyl 220 (150-300) S-adenosylmethionine
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arachidonic acid, havebeendetermined by theN-alkyl Edman
method in vitro (35).
Discussion
Background adducts (exemplified in Tables 2 and 3) may
reflectacarcinogenic load. Thisappears fromanassessmentof
thecontributions tothecancerriskofthedosesassociatedwith
observedadductlevels. ThecancerriskassociatedwithaHOEt-
Val background level of20pmole/gglobin maybeestimated as
follows. Thissteady-statelevelcorrespondstotheaccumulated
doseduringone-halfoftheerythrocyte lifespanandis inverse-
ly proportional to the rate constant, k,aI, for adductformation.
The annual dose, Dann, expressed in millimolar-hours peryear
(mMhr/year) will hencebe
Dann = 52 (weeks/year) * 20* 10-12(mole/g) 103 (mM/M)
9 (weeks) * 5 * 10 5 (L/g
- hr)
= 2.3 * 10-3 mM-hr/year
This dose may be assumed to behomogeneouslydistributed in
the body (45). One approach to estimate the cancer risk
associated with an observed adduct level is by expressing the
chemical dose in radiation dose equivalents, RadEq (46). For
ethylene oxide this value has been determined to 80 RadEq/
mMhr (47). The calculated dose equivalent would thus
amount to 0.0023 *80 = 0.18 RadEq/year.
TheNational ResearchCouncil (48)estimatedinitsBEIRV
report, fromthemultiplicativemodelapplied, thatinapopula-
tionofthecurrentagedistribution intheUnited States irradia-
tionwith 1 msv(=0.1 radlow-LETradiation) peryearwouldin-
creasethenumberofcancerdeathsbyabout3%, i.e., by about
600cases permillionpopulation. This model isalsoapplicable
togenotoxicchemicals (49), andanethyleneoxidedoseof0.18
RadEq/year wouldaccordingly increasethe riskby about 5%.
However, initscalculationofriskforsolidtumours,whichmake
upthe majorpartofthetotal cancerdeath rate, theBEIR com-
mittee did not allow for the lowering ofeffectiveness at lower
dose rates. This factor is certainly at least 3, most probably
around5 (Ehrenbergetal., inpreparation; 50)anditistherefore
prudenttogivetheriskassociatedwiththeHOEtValbackground
asbeingontheorderof1% ofthecurrentcancermortality (9).
For2-hydroxypropylvaline thelevel islowerthanthatofHOEt-
Valby oneorderofmagnitude, andtheassociatedrisk, assum-
ing the proximal reactive intermediate to be propylene oxide,
may be assumed to beproportionally smaller.
The identification of SAM as the main causative agent for
MeVal isheretakentoexemplifytheusefulnessofadductquan-
tificationandapplicationofreactionkineticsintheclarification
oforigin ofbackground adducts. Forthenextstep, riskestima-
tion, essentialdataarestilllacking, althoughreactionwithDNA.
in vitro has been demonstrated (51). The positively charged
sulfonium ion cannot be assumed to be homogeneously
distributedinthesamewayasacompoundsuchasethyleneox-
ide. Thedistribution inthebodyofanaturalmethylatorsuchas
SAM isprobablycompartmentalized, withaprotectionofDNA
against unwanted methylations. Forthis reasonandbecause of
theexistenceofaneffective system(methyltransferase) repair-
ing such methylations, conclusions about cancer risks due to
chemical methylations by SAM would require special studies
(9).
Duetotheirreactivity withDNAbasesandtheircross-linking
action and the mutagenic activity demonstrated for many
aldehydes (52,53), there are indications that thesecompounds
mayplayaroleincancerinitiation (54). Theestimationofcancer
risk from the doses of endogenously formed aldehydes, as
measuredbyHbadducts, cannotbedonecurrently. Studiesofthe
relationshipsbetweentissuedose(adductlevel)andtargetdose
andoftherelativegenotoxic potencyoftherespectivealdehydes
are fundamental to such estimation. It cannot be excluded that
endogenouslyformedaldehydesgiveaconsiderablecontribution
to the total loadofgenotoxic agents.
This manuscript was presented at the Conference on Biomonitoring and
Susceptibility Markers inHumanCancer: Applications in Molecular Epidem-
iology and RiskAssessmentthatwasheld inKailua-Kona, Hawaii, 26October-I
November 1991.
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